跳至主要内容
临床试验/CTRI/2022/05/042345
CTRI/2022/05/042345尚未招募2 期

Randomized controlled trial of Eranad mul arka eye drop with Olopetadine 0.1% eye drop in Vataj Abhishand W.S.R simple allergic conjunctivitis.

Vivek P Harne0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Both male and female
  • 2)Between the age group of 18 to 60 yrs will be included in the study.
  • 3)Patient suffering from Toda (pricking pain), Sangharsh (foreign body sensation), Vishushk Bhav (dryness feeling), Shishirasruta (cline/watery discharge), Alpashopha (mild chemosis) will be selected irrespective of their sex, education, socio economic status & religion.

排除标准

  • 1)Patient not willing for trial
  • 2)Pregnant & lactating women.
  • 3)Patient who need surgical and other in intervention.

研究者

发起方
Vivek P Harne

相似试验